Related Experiment Video
Updated: Aug 6, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Commercial Price Variation for Common Cardiovascular Services Across 4 Major US Insurers
Alexander P Philips1,2,3, Sanket S Dhruva4, Christopher Whaley1,3
1Center for Advancing Health Policy Through Research, Brown University School of Public Health, Providence, Rhode Island.
Commercial insurance payments for cardiology services show significant price variation between insurers and states, especially for facility fees. This highlights the need for increased transparency and oversight in healthcare pricing.
Area of Science:
- Health Economics
- Health Services Research
- Cardiology
Background:
- Cardiology services represent a significant portion of US healthcare expenditure.
- Understanding price variation is crucial for informed decision-making by employers, patients, and policymakers.
- Controlling costs and promoting value-based care necessitate insights into pricing dynamics.
Purpose of the Study:
- To quantify the variation in commercial insurance payment rates for common cardiology services.
- To analyze these payment rate variations across major US insurers and states.
- To leverage newly available Transparency in Coverage (TIC) data for this assessment.
Main Methods:
- A cross-sectional study utilizing April 2025 TIC data (reflecting 2023 claims).
- Inclusion of approximately 6.7 million professional and 104,563 facility price points for 32 cardiology services.
- Analysis across four major commercial insurers (BCBS, UHC, Aetna, Cigna) and nationwide physician/facility data.
Main Results:
- Substantial variation observed in allowed payment amounts for cardiology services across insurers and states.
- Facility negotiated price variation was notably higher than professional fee variation (median IQR of 2.56).
- Significant geographic price disparities were found, with examples like implantable cardioverter-defibrillator insertion and coronary angiography.
Conclusions:
- Commercial insurance payments for cardiology services exhibit considerable variation, particularly in facility fees.
- Payer contracting strategies and market dynamics significantly influence these price differences.
- Enhanced transparency and regulatory oversight are essential for promoting efficient healthcare spending.
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Variability: Analysis
The range is a simple measure of variability, indicating the difference between the highest and...
Pulse amplitude and quality
A weak or absent pulse may indicate reduced cardiac output or poor left ventricular contraction, which can be signs of cardiovascular dysfunction or...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Bioequivalence of Drugs: Drugs with Multiple Indications
Pathophysiology of Cardiac Performance
